Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Arterial Thrombotic Complications Are Uncommon in Patients without Cardiovascular Risk Factors and Occur at Equivalent Rates in Chronic Myeloid Leukemia (CML) Patients Treated with Imatinib and Nilotinib

Hesam Hekmatjou, MD, Gail J. Roboz, MD, Ellen K. Ritchie, MD, Sangmin Lee, MD, Pinkal Desai, MD, Joseph M. Scandura, MD PhD, Sandra Allen-Bard, ANP, BS, BSN, MSN, NP, Paul Christos, DrPH, Richard T. Silver, MD, Eric J. Feldman, MD

Blood (2014) 124 (21): 1811.

https://doi.org/10.1182/blood.V124.21.1811.1811

Published: 2014

Journal Articles

Arsenic Trioxide (ATO) Is Safe and Effective in Combination with Low-Dose Ara-C (LDAC) for the Treatment of IPSS-2 Myelodysplastic Syndrome (MDS) and Poor-Prognosis Acute Myeloid Leukemia (AML) in Elderly Patients.

Gail J. Roboz, MD, Ellen K. Ritchie, MD, Sandra Allen-Bard, N.P., Tania J. Curcio, R.N., Juliette L. Provenzano, MS, Michael S. Samuel, BA, Michael W. Schuster, MD, Alison W. Bloch, BA, Eric J. Feldman, MD

Blood (2005) 106 (11): 2805.

https://doi.org/10.1182/blood.V106.11.2805.2805

Published: 2005

Journal Articles

Gemtuzumab Ozogamicin Is an Acceptable Alternative to Anthracyclines in Combination with Standard Dose Infusional Cytarabine as Induction Therapy for Elderly Patients with Acute Myeloid Leukemia (AML).

Gail J. Roboz, MD, Ellen K. Ritchie, MD, Michael W. Schuster, MD, Tsiporah Shore, MD, Tania J. Curcio, R.N., Sandra Allen-Bard, N.P., Juliette L. Provenzano, MS, Eric J. Feldman, MD

Blood (2005) 106 (11): 1856.

https://doi.org/10.1182/blood.V106.11.1856.1856

Published: 2005

Journal Articles

Hydroxyurea Affects T-Lymphocyte Subsets in Sickle Cell Disease.

Devaki Sivasubramaniam, MD, Osei Bekoe, Bharat Motwani, MD, Sandra Allen, Lori Feldman, MD, Kenneth Beaman, PhD, Alice Gilman-Sachs, Lawrence E. Feldman, MD

Blood (2004) 104 (11): 3726.

https://doi.org/10.1182/blood.V104.11.3726.3726

Published: 2004

Journal Articles

A patient on hydroxyurea for sickle cell disease who developed an opportunistic infection

Pramila Venigalla, Bharat Motwani, Anitha Nallari, Sandra Allen, Manoj Agarwal, Manuel Alva, Maxwell Westerman, Lawrence Feldman

Blood (2002) 100 (1): 363–364.

https://doi.org/10.1182/blood-2002-03-0754

Published: 2002

NARROW

Arterial Thrombotic Complications Are Uncommon in Patients without Cardiovascular Risk Factors and Occur at Equivalent Rates in Chronic Myeloid Leukemia (CML) Patients Treated with Imatinib and Nilotinib

Arsenic Trioxide (ATO) Is Safe and Effective in Combination with Low-Dose Ara-C (LDAC) for the Treatment of IPSS-2 Myelodysplastic Syndrome (MDS) and Poor-Prognosis Acute Myeloid Leukemia (AML) in Elderly Patients.

Gemtuzumab Ozogamicin Is an Acceptable Alternative to Anthracyclines in Combination with Standard Dose Infusional Cytarabine as Induction Therapy for Elderly Patients with Acute Myeloid Leukemia (AML).

Hydroxyurea Affects T-Lymphocyte Subsets in Sickle Cell Disease.

A patient on hydroxyurea for sickle cell disease who developed an opportunistic infection

Email alerts

ASH Publications

American Society of Hematology

Arterial Thrombotic Complications Are Uncommon in Patients without Cardiovascular Risk Factors and Occur at Equivalent Rates in Chronic Myeloid Leukemia (CML) Patients Treated with Imatinib and Nilotinib

Arsenic Trioxide (ATO) Is Safe and Effective in Combination with Low-Dose Ara-C (LDAC) for the Treatment of IPSS-2 Myelodysplastic Syndrome (MDS) and Poor-Prognosis Acute Myeloid Leukemia (AML) in Elderly Patients.

Gemtuzumab Ozogamicin Is an Acceptable Alternative to Anthracyclines in Combination with Standard Dose Infusional Cytarabine as Induction Therapy for Elderly Patients with Acute Myeloid Leukemia (AML).

Hydroxyurea Affects T-Lymphocyte Subsets in Sickle Cell Disease.

A patient on hydroxyurea for sickle cell disease who developed an opportunistic infection

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only